TINA’S WISH GRANTS FOCUS ON EARLY DETECTION OF OVARIAN CANCER
Only 20 percent of women with ovarian cancer are diagnosed at an early stage when more successful treatment options are available, according to the American Cancer Society. Dana-Farber’s Dipanjan Chowdhury, PhD, and Jarrod Marto, PhD, have been awarded grants totaling $300,000 from The Honorable Tina Brozman Foundation, also known as “Tina’s Wish,” to pursue innovative research on theearly detection of ovarian cancer.